Hui Peng

Hunan University of Traditional Chinese Medicine — China

Medicine · Health Sciences

15h-index1.0kcitations41works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinal Diseases and Treatments(6), Virus-based gene therapy research(6), Sulfur Compounds in Biology(6), Viral Infectious Diseases and Gene Expression in Insects(6), Mitochondrial Function and Pathology(5)

Publications41 total

Dysbiosis of the gut micro-flora aggravates symptoms and accelerates disease progression in MASLD-IBD Co-morbid mice through host-microbial metabolic imbalance
Archives of Biochemistry and Biophysics·2025· 1 cited
The Role of Gut Microbiota on Intestinal Fibrosis in Inflammatory Bowel Disease and Traditional Chinese Medicine Intervention
Journal of Inflammation Research·2025· 2 citedOpen Access
Investigation of PANoptosis pathway in age-related macular degeneration triggered by Aβ1-40
Scientific Reports·2025· 2 citedOpen Access
The intestinal microbiota modulates the visceral sensitivity involved in IBS induced by restraint combined with tail clustering
Frontiers in Cellular and Infection Microbiology·2025· 2 citedOpen Access
Atorvastatin Alleviates Age-Related Macular Degeneration via AIM2-Regulated Pyroptosis
Inflammation·2024· 3 citedOpen Access
Data from Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
2023Open Access
Data from Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
2023Open Access
Supplementary Data from Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
2023Open Access
Supplementary Data from Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
2023Open Access
Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma
Cancer Research·2022· 52 citedOpen Access
Utility of the DHFR-based destabilizing domain across mouse models of retinal degeneration and aging
iScience·2022· 4 citedOpen Access
Recovery Infectious Enterovirus 71 by Bac-to-Bac Expression System in vitro and in vivo
Frontiers in Microbiology·2022· 2 citedOpen Access
SUFFICIENT ACTIVITY OF THE UBIQUITIN PROTEASOME SYSTEM IN AGED MICE AND DURING RETINAL DEGENERATION SUPPORTS DHFR-BASED CONDITIONAL CONTROL OF PROTEIN ABUNDANCE IN THE RETINA
2021Open Access
Multifaceted role of branched-chain amino acid metabolism in cancer
Oncogene·2020· 246 citedOpen Access
Simultaneous Control of Endogenous and User-Defined Genetic Pathways Using Unique ecDHFR Pharmacological Chaperones
Cell chemical biology·2020· 13 citedOpen Access
Non-antibiotic Small-Molecule Regulation of DHFR-Based Destabilizing Domains In Vivo
Molecular Therapy — Methods & Clinical Development·2019· 17 citedOpen Access
Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology
International Journal of Molecular Sciences·2019· 6 citedOpen Access
A destabilized domain-based approach to control protein abundance in aged mice and models of retinal degeneration
2019
Versatile, non-antibiotic control of an ocular DHFR-based destabilizing domain
Investigative Ophthalmology & Visual Science·2019Open Access
Small Molecule-Based Inducible Gene Therapies for Retinal Degeneration
Advances in experimental medicine and biology·2019· 7 cited
page 1 of 3Next →

Frequent Co-authors

John D. Hulleman(8), David Giedroc(7), Yingfei Wang(6), Weibo Luo(6), Shyamtanu Datta(6), Lei Bao(5), Chenliang Wang(5), Hongxia Zhang(5), Jennifer E. Wang(5), Yan-Ling Niu(5), Yan Chen(5), Yijie Wang(5), Kimmo J. Hatanpaa(5), John A. Copland(5), Ralph J. DeBerardinis(5), Marian Renwick(5), Jiangchuan Shen(4), Yixiang Zhang(4), Jonathan C. Trinidad(4), James M. Wilson(4)